Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1CNS 1

Conditions

Smoke Inhalation Injury 1Respiratory Aspiration 1Neoplasms 1Lung Neoplasms 1Lung Diseases, Interstitial 1Lung Diseases 1Brain Neoplasms 1

Interventions

pembrolizumab 1280Specimen Handling 928Carboplatin 836Magnetic Resonance Spectroscopy 831Cyclophosphamide 807Cisplatin 735Nivolumab 679Paclitaxel 634Radiotherapy 617Gemcitabine 579Biopsy 560Bevacizumab 486Dexamethasone 444fludarabine 409Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 363Fluorouracil 358atezolizumab 353durvalumab 339Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 320Blood Specimen Collection 315Standard of Care 311Pemetrexed 308Ipilimumab 303Radiation 289

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Health Records, Personal × 1 year × Clear all
NCT06836414 2026-04-13

Lung Cancer Screening CT for Firefighters

University of California, San Francisco

Phase NA Withdrawn
Thoracic

Lung Diseases, Lung Neoplasms, Smoke Inhalation Injury, Lung Diseases, Interstitial, Respiratory Aspiration

NCT05102747 2026-01-27

OligoBM-01

Centre Francois Baclesse

Phase NA Recruiting
504 enrolled
CNS

Brain Neoplasms

NCT04732273 2025-09-23

SCCSS-FU

University of Bern

Recruiting
3,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡